SSPL WEALTH PVT LTD

Thursday 03 Apr, 2025 08:24 AM

Maruti Suzuki to hike car prices from April 8 LTIMindtree gains on joining hands with PHINIA Inc Focus Lighting and Fixtures hits the roof after securing multiple orders worth Rs 9-cr Godrej Properties rallies after selling homes worth over Rs 2,000 crore in Noida Artson hits the roof on appointing Manoj Shah as CFO Banco Products gains as arm expands production capacity in Poland Gujarat Natural Resources jumps 47% in nine days Central Bank of India leads losers in 'A' group GPT Infra jumps on bagging order worth Rs 481-cr for railway project Punjab & Sind Bank leads losers in 'B' group Refex Renewables rallies on bagging Rs 65-cr tender Surya Roshni's steel pipe & strips divions registers sales volume of 1,00,239 MT in March'25 Volumes jump at Quess Corp Ltd counter Hi-Tech Pipes registers 24% YoY increase in FY25 sales volume; quartely sales at 1,16,032 MT Capital Goods stocks edge lower

Saravan Stocks

Stock Alert

Overall view of all the recent market developments which will help in your investment decisions

Stock Alert: RPP Infra, Zydus Life, Shilpa Medicare, Quality Power, Alkem Lab

17-Mar-25 08:32 Hrs IST

Securities in F&O Ban:

BSE, IndusInd Bank, Hindustan Copper, Manappuram Finance and SAIL shares are banned from F&O trading on Monday, 17 March 2025.

Stocks to Watch:

Quality Power Electrical Equipment's consolidated net profit jumped 23% to Rs 13.83 crore in Q3 FY25 as compared with Rs 11.24 crore. Net sales declined 48.9% YoY to Rs 72.59 crore during the quarter ended 31st December 2024.

RPP Infra Projects received a letter of acceptance for a new project worth Rs 22.56 crore from the Department of Space Centre, Construction and Maintenance Group, Sriharikota.

Zydus Lifesciences announced that the US Food and Drug Administration (USFDA) conducted a surveillance inspection at the company's Active Pharmaceutical Ingredient (API) Unit 1, located in Ankleshwar, Gujarat.

Shilpa Medicare announced that the United States Food and Drug Administration (USFDA) conducted an inspection at Unit-2 of its subsidiary, Shilpa Pharma Lifesciences, located in Raichur, with zero observations.

Tata Communications announced the appointment of N. Ganapathy Subramaniam as the chairman of the board of directors of the company, effective from 14 March 2025.

JB Chemicals & Pharmaceuticals' API (Active Pharmaceutical Ingredient) manufacturing facility (D9) in Panoli, Gujarat, successfully cleared a US Food and Drug Administration (USFDA) inspection without any observations.

G R Infraprojects announced that it has been selected as the preferred bidder for the Agra-Gwalior Greenfield Road Project, tendered by the National Highways Authority of India (NHAI) under the Ministry of Road Transport and Highways.

Alkem Laboratories announced that the United States Food and Drug Administration (USFDA) conducted a Bioresearch Monitoring (BIMO) inspection at its Bioequivalence Center in Taloja, Maharashtra, from 10 March to 13 March 2025.

Powered by Capital Market - Live News

Attention Investors :

Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.

Attention Investors :

Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.

Attention Investors :

KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Attention Investors :

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

Email ID: info@ssplwealth.com Customers grievances : grievances@ssplwealth.com Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com, Mobile No: 7305522205

Hit Count : 39945428

Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified)